Roe Granger News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Troutman Pepper client Palvella Therapeutics, Inc., a late clinical-stage biopharmaceutical company, recently announced the initial closing of its Series D financing of up to $37.7 million.

Chris millerPachyonychia congenitaRoe grangerStephen foxNeil dooganPalvella therapeutics incTroutman pepperPalvella therapeuticsGore rangeSamsara biocapitalAgent capitalNolan capitalRead palvellaMicrocystic lymphatic malformationsPennsylvania recordPepper hamilton llp